Active Comparator Radiation,Experimental Radiation
Sponsors
Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Universiti Sains Malaysia (USM) - Research University Grant, Radiation oncology division, Radiology Department, KCMH, Pitchayaponne Klunklin
Conditions
-Breast cancer patients stage II-III aged 18 years or older who undergo breast conserving surgery with free surgical margins from both invasive carcinoma and ductal carcinoma in situ (DCIS) and are planned to receive whole breast radiation with tumor bed boost with or without regional lymph node radiation.
Ultrahypofractionation, moderated hypofractionation, breast cancer, radiotherapyGastric disordersbone metastatic patients
bone metastases
bone metastatic pain
cancer patients
Early Phase 1
Phase 2
Single fraction of proton stereotactic body radiotherapy (SBRT) versus multiple fraction of photon SBRT for bone metastatic patients
RecruitingTCTR20220615009
Start: 2022-08-01Target: 136Updated: 2026-08-03
Comparison of ultra- and moderate hypofractionation with boost in whole breast and regional node radiotherapy for breast cancer treatment
Active, not recruitingTCTR20260416007
Start: 2026-04-09Target: 414Updated: 2026-08-03